Emre Yekedüz: A Meta-Analysis From The DADSPORT Collaboration For Nonmetastatic Prostate Cancer
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, shared a post on X:
“A meta-analysis from the DADSPORT Collaboration:
Adding hormone therapy to post-op radiotherapy in nonmetastatic prostate cancer improves:
Metastasis-free survival (HR=0.78)
Prostate cancer–specific survival (HR=0.61)
Overall survival benefit small (HR=0.86), limited to high-risk patients.
Title: Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data
Authors: Sarah Burdett, David J. Fisher, Jayne F. Tierney, Adrian D. Cook, Daniel E. Spratt, James J. Dignam, Wendy F. Seiferheld, Amar U. Kishan, Yilun Sun, Sylvie Chabaud, Jason A. Efstathiou, Christopher C. Parker, Alan Pollack, Paul Sargos, Igor Latorzeff, Meryem Brihoum, Charles N. Catton, Noel W. Clarke, Felix Y. Feng, Theodore G. Karrison, Pascal Pommier, Howard M. Sandler, Matthew R. Sydes, Claire L. Vale
You can read the Full Article on Elsevier
More posts featuring Emre Yekedüz.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023